AstraZeneca Pharma India Limited is a pharmaceutical company. The Company operates in three segments: healthcare, clinical trial services and co-promotional services. The healthcare segment is engaged in the manufacture and sale of pharmaceutical products. The clinical trial services segment offers clinical trial services on pharmaceutical products. The Co-promotional services segment offers co-promotion services for pharmaceuticals products to its customers. The Company�s brands include Crestor, Seloken, Selomax, Meronem, Neksium and Linctus Codeinae. The Company launched Remergin (Colistimethate sodium) and Rhinomax (montelukast sodium and levocetirizine dihydrochloride) and one line extension in the infection therapeutic area. The Company produces bulk drugs, liquids, tablets and capsules, injectables, ointments and inhalation products. The Company is a subsidiary of AstraZeneca Pharmaceuticals AB.